Non-invasive predictive factors of complete cytoreduction at interval debulking surgery in advanced epithelial ovarian cancer

被引：0
|
作者：
Candotti, Giorgio [1 ]
Pavone, Giacomo [1 ]
Bocciolone, Luca [1 ]
Vasta, Francesca [1 ]
Galli, Federica [1 ]
Di Filippo, Marianna [1 ]
Rabaiotti, Emanuela [1 ]
Bergamini, Alice [1 ,2 ]
Shai, Daniel [3 ,4 ]
De Marzi, Patrizia [1 ]
Pella, Francesca [1 ]
Taccagni, Gianluca [5 ]
Sant'Angelo, Miriam [5 ]
机构：
[1] IRCCS San Raffaele Hosp, Dept Obstet & Gynecol, Milan, Italy
[2] Univ Vita Salute San Raffaele, Milan, Italy
[3] Sheba Med Ctr, Dept Gynecol Oncol, Tel Hashomer, Israel
[4] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel
[5] IRCCS San Raffaele Hosp, Dept Surg Pathol, Milan, Italy
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2024年 / 34卷 / SUPPL_1期
关键词：
D O I：
10.1136/ijgc-2024-ESGO.684
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
610
引用
收藏
页码：A350 / A350
页数：1
相关论文
共 50 条
  • [41] Primary debulking surgery or neoadjuvant chemotherapy followed by interval debulking surgery for patients with advanced ovarian cancer
    Zheng, Hong
    Gao, Yu-Nong
    CHINESE JOURNAL OF CANCER RESEARCH, 2012, 24 (04) : 304 - 309
  • [42] Assessing feasibility and perioperative outcomes with minimally invasive surgery compared with laparotomy for interval debulking surgery with hyperthermic intraperitoneal chemotherapy for advanced epithelial ovarian cancer
    Morton, Molly
    Chambers, Laura M.
    Costales, Anthony B.
    Chichura, Anna
    Gruner, Morgan
    Horowitz, Max P.
    Rose, Peter G.
    Yao, Meng
    Debernardo, Robert
    Michener, Chad
    GYNECOLOGIC ONCOLOGY, 2021, 160 (01) : 45 - 50
  • [43] Residual tumor and primary debulking surgery vs interval debulking surgery in stage IV epithelial ovarian cancer
    Sorensen, Sarah Mejer
    Hogdall, Claus
    Mosgaard, Berit Jul
    Dalgaard, Maya Isabella Riise
    Jensen, Mai Partridge
    Fuglsang, Katrine
    Schnack, Tine Henrichsen
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2022, 101 (03) : 334 - 343
  • [44] Factors that predict optimal debulking at interval cytoreductive surgery after neoadjuvant chemotherapy in epithelial ovarian cancer
    Boccaccio, R. B.
    Crim, A. K.
    Osborn, K.
    Ding, K.
    Moore, K. N.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 82 - 82
  • [45] A predictive score for optimal cytoriduction at interval debulking surgery in epithelial ovarian cancer: a single-institution experience
    Ghisoni, E.
    Maggiorotto, F.
    Marocco, F.
    Ponzone, R.
    Robella, M.
    Vaira, M.
    Scarafia, C.
    Valabrega, G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 700 - 700
  • [46] RESULTS ON FEASIBILITY RCT ON USE OF (PlasmaJet) TO ACHIEVE COMPLETE CYTOREDUCTION DURING DEBULKING FOR EPITHELIAL OVARIAN CANCER
    Madhuri, T. K.
    Butler-Manuel, S.
    Ellis, P.
    Tailor, A.
    Williams, P.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 509 - 509
  • [47] RESULTS ON FEASIBILITY RCT ON USE OF (PLASMAJET) TO ACHIEVE COMPLETE CYTOREDUCTION DURING DEBULKING FOR EPITHELIAL OVARIAN CANCER
    Madhuri, T. K.
    Butler-Manuel, S.
    Ellis, P.
    Tailor, A.
    Williams, P.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1584 - 1584
  • [48] CT-Based Fagotti Scoring System for Non-Invasive Prediction of Cytoreduction Surgery Outcome in Patients with Advanced Ovarian Cancer
    Kim, Na Young
    Jung, Dae Chul
    Lee, Jung Yun
    Han, Kyung Hwa
    Oh, Young Taik
    KOREAN JOURNAL OF RADIOLOGY, 2021, 22 (09) : 1481 - 1489
  • [49] Minimally invasive interval debulking surgery after neoadjuvant chemotherapy for ovarian cancer
    Seagle, B. L. L.
    Yang, J.
    Kocherginsky, M.
    Shahabi, S.
    GYNECOLOGIC ONCOLOGY, 2018, 149 (03) : 629 - 630
  • [50] Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer
    Vergote, Ignace
    Amant, Frederic
    Kristensen, Gunnar
    Ehlen, Tom
    Reed, Nick S.
    Casado, Antonio
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S88 - S92
12345